Our Mission
The Oxford Vaccine Group has been at the forefront of vaccine development for 30 years, helping to fight diseases of major global importance through research and education around the world.
What's Happening?
Study Spotlight
🌍 Malaria remains a global health challenge with 240 million cases and 627,000 deaths in 2020. But we're on a mission to change this. Learn more about our groundbreaking malaria vaccine study below. Let's eradicate malaria together!
Be a Vaccine Hero
Take part in a study
Could you be a Vaccine Hero by taking part in one of our clinical trials? Find out about the trials and studies currently looking for volunteers, as well as what it is like taking part from previous participants.
Study - BIO-004
We are looking for volunteers aged from 18 to 45 years old to take part in a challenge study to investigate how the immune system responds to repeated malaria infection. We will reimburse you up to £9,100 for your time, inconvenience, and travel.
Study - RESPECCT
A challenge study to investigate RSV and SPN co-infection to understand how these two common germs alter the nose environment and impact human health.
Study - RHYME
A children's study to determine if 2 investigational vaccines could help prevent Respiratory syncytial virus (RSV) and Human metapneumovirus (hMPV) infection
Research at OVG
Education, Learning and Public Involvement
Latest Publications
⠀⠀⠀⠀⠀
-
Journal article
El Safadi D. et al, (2024), J Infect Dis
-
Preprint
Fairfax B. et al, (2024)
-
Journal article
Kariuki SN. et al, (2024), J Infect Dis
-
Journal article
Dyson ZA. et al, (2024), Lancet Microbe